Working actively
for better health
The Endowment Fund supports projects and actions linked to mental and physical health.
IHU ICAN
From the numerous fields of medical research offered by the IHU-ICAN (University Hospital Institute for Innovation in Cardiometabolism and Nutrition) Foundation, we focus on physical health: diabetes and liver disease issues in particular.
The Endowment Fund and IHU-ICAN have joined forces to accelerate the application of fundamental and clinical research findings to treatment for patients with cardiovascular and metabolic diseases.
Stéphane Hatem
Managing Director of IHU ICAN
Sponsorship plays an essential role in research into cardiometabolic diseases. Sicame Group’s support helps finance innovative projects that lead to significant advances, accelerating our understanding of cardiometabolic diseases and paving the way for more effective patient care. Sponsorship is not just about financial support, it is also a driving force behind scientific advances in this vital field for the millions of people living with cardiometabolic disease.
Founded in
2011
the IHU ICAN (Foundation for Innovation in Cardiometabolism and Nutrition) is a center of excellence for research in cardiometabolic diseases:
diabetes, obesity, Metabolic Dysfunction-Associated Steatohepatitis (MASH), heart and vascular diseases.
Based within the Pitié-Salpêtrière Hospital in Paris, the Foundation draws on the expertise of its founders: AP-HP, INSERM and Sorbonne University. It is made up of internationally renowned experts in clinical and fundamental research who are developing the personalized medicine of tomorrow to better prevent, predict and treat cardiometabolic diseases.
- +400physicians and researchers
- +6 000scientific publications
- 7cutting-edge technological platforms
